Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11192877 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

Patent 11192877 was granted and assigned to Novartis on December, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Novartis

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

111928770

Patent Inventor Names

Philip Lam0

Simone Bonazzi0

Artiom Cernijenko0

Claire Adcock0

Hasnain Ahmed Malik0

Kathryn Taylor Linkens0

Michael Scott Visser0

Noel Marie-France Thomsen0

Date of Patent

December 7, 2021

Patent Application Number

165043750

Date Filed

July 8, 2019

Patent Citations Received

‌

US Patent 12122764 IKAROS zinc finger family degraders and uses thereof

Patent Primary Examiner

‌

Taylor V Oh

Patent abstract

The present disclosure provides a compound of Formula (I′):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11192877 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API